Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 25, 2023
April 11, 2024
b83095c6-9f4a-4d0e-bbb2-0e2c8a11e2f1
Related Documents
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Mpox: Development of Drugs and Biological Products; Guidance for Industry
Guidance DocumentJanuary 19, 2023Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products
Guidance DocumentSeptember 7, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox